Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 24, 2026 · Filed Jun 23, 2026
The CEO of Tempest Therapeutics paid $500K out of pocket for Tempest Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$500,001
Shares × reported transaction price
$500K–$1M
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
6 days before results of Mar 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.75 on Mar 24, 2026, 37% above its 52-week low and 70% below its high, after a 24% drop over the previous 30 trading days
52-week range $1.28 (Jan 14, 2026) to $5.92 (Oct 14, 2025), 10% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.30 on Feb 9, 2026. Describes the past only, not a forecast
RSI 32, 48% under its 200-day average, 16% under its 50-day average, 70% below the 52-week high, 20-day volatility 91% a year, against the S&P 500: −23 points over 1 month, +16 points over 3 months, −61 points over 6 months
From the adjusted closes up to Mar 24, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.3% | +1.7% | −6.0% |
| 30 days | −20.2% | +0.8% | −21.0% |
| 90 days | −13.8% | +5.5% | −19.3% |
Past results only. Not a forecast.
Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Insider filing
Traded Mar 24 · filed 91 days later
Not classified as an open-market trade.
Insider filing
Traded Jun 4 · filed 13 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.